FHIR IG Statistics: ValueSet/2.16.840.1.113883.3.1444.3.194
| Package | us.nlm.vsac |
| Resource Type | ValueSet |
| Id | 2.16.840.1.113883.3.1444.3.194 |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.1444.3.194/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.194 |
| Version | 20250409 |
| Status | active |
| Date | 2025-04-09T01:09:28-04:00 |
| Name | TrastuzumabInjectable |
| Title | Trastuzumab Injectable |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: The purpose of this value set is to represent concepts of medication Trastuzumab.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication Trastuzumab and biosimilars; generic; prescribable; injectable.),(Exclusion Criteria: Excludes trastuzumab emtansine.) |
Resources that use this resource
Resources that this resource uses
Narrative
No narrative content found in resource
Source
{
"resourceType": "ValueSet",
"id": "2.16.840.1.113883.3.1444.3.194",
"meta": {
"versionId": "25",
"lastUpdated": "2025-04-09T01:09:28.000-04:00",
"profile": [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail": {
"name": "American Society of Clinical Oncology Author"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate": "2025-04-09"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate": "2025-04-09"
}
],
"url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.194",
"identifier": [
{
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113883.3.1444.3.194"
}
],
"version": "20250409",
"name": "TrastuzumabInjectable",
"title": "Trastuzumab Injectable",
"status": "active",
"date": "2025-04-09T01:09:28-04:00",
"publisher": "American Society of Clinical Oncology Steward",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "US"
}
]
}
],
"purpose": "(Clinical Focus: The purpose of this value set is to represent concepts of medication Trastuzumab.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication Trastuzumab and biosimilars; generic; prescribable; injectable.),(Exclusion Criteria: Excludes trastuzumab emtansine.)",
"compose": {
"include": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"concept": [
{
"code": "1922509",
"display": "trastuzumab 150 MG Injection"
},
{
"code": "2107053",
"display": "trastuzumab-pkrb 21 MG/ML Injectable Solution"
},
{
"code": "2119714",
"display": "5 ML hyaluronidase-oysk 2000 UNT/ML / trastuzumab-oysk 120 MG/ML Injection"
},
{
"code": "2169359",
"display": "trastuzumab-pkrb 150 MG Injection"
},
{
"code": "2174804",
"display": "trastuzumab-anns 21 MG/ML Injectable Solution"
},
{
"code": "2179753",
"display": "trastuzumab-dkst 150 MG Injection"
},
{
"code": "2179760",
"display": "trastuzumab-dkst 21 MG/ML Injectable Solution"
},
{
"code": "2257297",
"display": "trastuzumab-anns 150 MG Injection"
},
{
"code": "2280732",
"display": "trastuzumab-qyyp 21 MG/ML Injectable Solution"
},
{
"code": "2289227",
"display": "trastuzumab-dttb 150 MG Injection"
},
{
"code": "2289234",
"display": "trastuzumab-dttb 21 MG/ML Injectable Solution"
},
{
"code": "2472791",
"display": "trastuzumab-qyyp 150 MG Injection"
}
]
}
]
},
"expansion": {
"identifier": "urn:uuid:f2759c8f-68c9-4004-b394-8e1daf1767c4",
"timestamp": "2025-05-23T21:54:28-04:00",
"total": 12,
"contains": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1922509",
"display": "trastuzumab 150 MG Injection"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "2107053",
"display": "trastuzumab-pkrb 21 MG/ML Injectable Solution"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "2119714",
"display": "5 ML hyaluronidase-oysk 2000 UNT/ML / trastuzumab-oysk 120 MG/ML Injection"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "2169359",
"display": "trastuzumab-pkrb 150 MG Injection"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "2174804",
"display": "trastuzumab-anns 21 MG/ML Injectable Solution"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "2179753",
"display": "trastuzumab-dkst 150 MG Injection"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "2179760",
"display": "trastuzumab-dkst 21 MG/ML Injectable Solution"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "2257297",
"display": "trastuzumab-anns 150 MG Injection"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "2280732",
"display": "trastuzumab-qyyp 21 MG/ML Injectable Solution"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "2289227",
"display": "trastuzumab-dttb 150 MG Injection"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "2289234",
"display": "trastuzumab-dttb 21 MG/ML Injectable Solution"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "2472791",
"display": "trastuzumab-qyyp 150 MG Injection"
}
]
}
}
FHIR